Non-hypoxic preconditioning of myocardium against postoperative atrial fibrillation: Mechanism based on enhancement of the antioxidant defense system

Medical Hypotheses

Volumn 69, Issue 6, 2007, Pages 1242-1248

  Rodrigo, Ramón ^a   Castillo, Rodrigo ^a   Cereceda, Mauricio ^b   Asenjo, René ^b   Zamorano, Jaime ^b   Araya, Julia ^c  

^a Institute of Biomedical Sciences   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ANTIOXIDANT ACTIVITY; ARTICLE; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; NONHUMAN; OXIDATIVE STRESS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REPERFUSION INJURY;

ANIMALS; ANOXIA; ANTIOXIDANTS; ATRIAL FIBRILLATION; ELECTROPHYSIOLOGY; FATTY ACIDS, UNSATURATED; HEART ATRIA; HUMANS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; MYOCARDIUM; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; REACTIVE OXYGEN SPECIES; TREATMENT OUTCOME;

EID: 35549002771     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.03.035     Document Type: Article

References (53)

1. Ommen S., Odell K., and Stanon M. Atrial arrhythmias after cardiothoracic surgery. N Engl J Med 336 (1997) 1429-1434
2. Korantzopoulos P., Kolettis T., Siogas K., et al. Atrial fibrillation and electrical remodeling: the potential role of inflammatory and oxidative stress. Med Sci Monit 9 (2003) RA225-RA229
3. Van Wagoner D.R. Molecular basis of atrial fibrillation: a dream or a reality?. J Cardiovasc Electrophysiol 14 (2003) 667-669
4. Mihm M., Yu F., Carnes C., et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104 (2001) 174-180
5. Carnes C., Chung M., Nakayama T., et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodelling and decrease the incidence of postoperative atrial fibrillation. Circ Res 89 (2001) E32-E38
6. Galaris D., and Korantzopoulos P. On the molecular mechanism of metamyoglobin-catalyzed reduction of hydrogen peroxide by ascorbate. Free Radic Biol Med 22 (1997) 657-667
7. Dhalla N.S., and Temsah R.M. Sarcoplasmatic reticulum and cardiac oxidative stress: an emerging target for heart disease. Expert Opin Targets 5 (2001) 205-217
8. Van Wagoner D.R. Redox modulation of cardiac electrical activity. J Cardiovasc Electrophysiol 12 (2001) 183-184
9. Dhalla N., Temsah R., and Netticadan D. Role of oxidative stress in cardiovascular disease. J Hypertens 18 (2000) 655-673
10. Loh S., Jin J., Tsai C., et al. Possible underlying mechanism for hydrogen peroxide-induced electromechanical suppression in human atrial myocardium. J Hypertens 91 (2003) 53-60
11. Abraham R., Matza M., Marmor S., et al. Electromechanical impairment of human auricule and rat myocardial strip subjected to exogenous oxidative stress. Eur J Cardiothorac Surg 23 (2003) 66-73
12. Carnés C., Nakayama H., Nakayama T., et al. Redox modulation of atrial calcium current and contractility: altered response to beta-adrenergic stimulation. Heart Rhythm 2 (2005) S256
13. Griendling K., Sorescu D., and Ushio Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86 (2000) 494-501
14. Li J.-M., Gall N., Grive D., Chen M., et al. Activation of NAD(P)H oxidase during progression of cardiac hypertrophy to failure. Hypertension 40 (2002) 477-484
15. Heymes C., Bendall J., Ratajezak P., et al. increased myocardial NAD(P)H oxidase activity in human heart failure. J Am Cell Cardiol 41 (2003) 2164-2171
16. Kim Y., Guzik T., Zhang Y., et al. A myocardial Nox 2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res 97 (2005) 629-636
17. Aon M., Cortassa S., Marban E., et al. Synchronized whole cell oscillations in mitochondrial metabolism triggered by a local release of reactive oxygen species in cardiac myocytes. J Biol Chem 278 (2003) 44735-44744
18. Grant A.O. Molecular biology of sodium channels and their role in cardiac arrhythmias. Am J Med 110 (2001) 296-305
19. Olson T., Michels V., Ballew J., et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. J Am Med Assoc 293 (2005) 447-454
20. Barrington P.L., Martin R.L., and Zhang K. Slowly inactivating sodium currents are reduced by exposure to oxidative stress. J Mol Cell Cardiol 29 (1997) 3251-3265
21. Dobrev D., and Ravens U. Remodeling of cardiomyocyte ion channels in human atrial fibrillation. Basic Res Cardiol 98 (2003) 137-148
22. Jouven X., Charles M.A., Desnos M., and Ducimetiere P. Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation 104 (2001) 756-761
23. Mozaffarian D., Psaty B., Rimm E., et al. Fish intake and risk of incident atrial fibrillation. Circulation 110 (2004) 368-373
24. Kang J., and Leaf A. Antiarrhythmic effects of polyunsaturated fatty acids: recent studies. Circulation 94 (1997) 1774-1780
25. Siscovick D., Raghunathan T., King I., et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and risk of primary cardiac arrest. JAMA 274 (1995) 1363-1367
26. Leaf A. Electrophysiologic basis for the antiarrhythmic and anticonvulsant effects of omega 3 polyunsaturated fatty acids. World Rev Nutr Diet 88 (2001) 72-78
27. Kang J., and Leaf A. Prevention and termination of arrhythmias induced by lysophosphatidyl choline and acylcarnitine in neonatal rat cardiac myocytes by free omega-3 polyunsaturated fatty acids. Eur J Pharmacol 297 (1996) 97-106
28. McLennan P., Bridle T., Abeywardena M., et al. Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey. Am Heart J 123 (1992) 1551-1561
29. + channel. P Natl Acad Sci USA 95 (1998) 2680-2685
30. Kang J., Xiao Y.-F., and Leaf A. Free long-chain polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes. P Natl Acad Sci USA 92 (1995) 3997-4001
31. Alexander-North L.S., North J.A., Kiminyo K.P., Buettner G.R., and Spector A.A. Polyunsaturated fatty acids increase lipid radical formation induced by oxidant stress in endothelial cells. J Lipid Res 35 (1994) 1773-1785
32. van Ginkel G., and Sevanian A. Lipid peroxidation-induced membrane structural alterations. Methods Enzymol 233 (1994) 273-288
33. Perry G., Raina A.K., Nunomura A., Wataya T., Sayre L.M., and Smith M.A. How important is oxidative damage? Lessons from Alzheimer's disease. Free Radic Biol Med 28 (2000) 831-834
34. 2+ dynamics and antioxidant status. Free Radic Biol Med 40 (2006) 1592-1602
35. Chung M.K. Cardiac surgery: postoperative arrhythmias. Crit Care Med 28 Suppl (2000) N136-N144
36. Bruins P., Velthuis H., and Yazdanhakhsh A. Activation of the complement system during and after cardiopulmonary bypass surgery. Circulation 96 (1997) 3542-3548
37. Kawano S., Kubota T., Monden Y., Tsutsumi T., Inoue T., Kawamura N., et al. Blockade of NF-κB improves cardiac function and survival after myocardial infarction. Am J Physiol Heart Circ Physiol 291 (2006) H1337-H1344
38. Yamamoto Y., and Gaynor R.B. Role of the NF-κB pathway in the pathogenesis of human disease states. Curr Mol Med 1 (2001) 287-296
39. Pan M., Zhu J.H., Jiang W.P., et al. Inflammation: a possible pathogenic link to atrial fibrillation. Med Hypotheses 67 (2006) 1305-1307
40. Bowie A., and O'Neill L.A. Oxidative stress and nuclear factor-κB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 59 (2000) 13-23
41. Frustaci A., Chimenti C., Bellocci F., et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96 (1997) 1180-1184
42. Ulker S., McKeown P.P., and Bayraktutan U. Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension 41 (2003) 534-539
43. Bedard K., and Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87 (2007) 245-313
44. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999;354:447-55.
45. Albert C., Campos H., Stampfer M., et al. Blood levels of long-chain n-3 fatty acids and risk of sudden death. N Engl J Med 346 (2002) 1113-1118
46. Lemaitre R., King I., Mozaffarian D., et al. Plasma phospholipids n-3 polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal MI in older adults-CHS. Am J Clin Nutr 77 (2003) 319-325
47. Mozaffarian D., Lemaitre R., Kuller L., et al. Cardiovascular health study. Cardiac benefits of fish consumption may depend on the type of fish meal consumed-CHS. Circulation 107 (2003) 1372-1377
48. Jahangiri A., Leifert W., Patten G., et al. Termination of asynchronous contractile activity in rat atrial myocytes by n-3 polyunsaturated fatty acids. Mol Cell Biochem 206 (2000) 33-41
49. Caló L., Bianconi L., Colivicchi F., Lamberti F., Loricchio M.L., de Ruvo E., et al. N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 45 (2005) 1723-1728
50. Shiroshita-Takeshita A., Scram G., Lavoie J., et al. Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs. Circulation 110 (2004) 2313-2319
51. Korantzopoulos P., Kolettis T., Kountouris E., et al. Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. Int J Cardiol 102 (2005) 321-326
52. Nguyen T.K., Nilakantan V., Felix C.C., Khanna A.K., and Pieper G.M. Beneficial effect of alpha-tocopheryl succinate in rat cardiac transplants. J Heart Lung Transplant 25 (2006) 707-715
53. Behrendt D., Beltrame J., Hikiti H., et al. Impact of coronary endothelial function on the progression of cardiac transplant-associated arteriosclerosis: effect of anti-oxidant vitamins C and E. J Heart Lung Transplant. 25 (2006) 426-433